Drugs / ALGLUCERASE
ALGLUCERASE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00001416 | Dec 1993 → Nov 2000 | Gaucher disease type I | National Institute of Neurological Disorders and Stroke (NINDS) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALGLUCERASE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201633 ↗ |
| Known as | Alglucerasa | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201633 ↗ |
| Known as | CEREDASE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001416 ↗ |
| Modality | Protein / enzyme biologic | “repeated infusions of macrophage-targeted glucocerebrosidase” NCT00001416 ↗ |